Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Oct 9, 2020 at 12:20 PM EDT

4 Very Profitable Biotech Stocks Expected to Soar Into 2021

24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive…

Chris Lange | Oct 8, 2020 at 12:33 PM EDT

Spinal Elements IPO Set to Turn Necks

Medical device company Spinal Elements Holdings intends to price more than 7 million shares for an initial public offering valued…

Chris Lange | Oct 8, 2020 at 11:51 AM EDT

Could Applied Therapeutics Stock Rise 300%?

Applied Therapeutics shares pushed higher on Thursday after a new analyst report came out supposing massive upside for this biotech.

Douglas A. McIntyre | Oct 8, 2020 at 7:36 AM EDT

This State Has the Fewest COVID-19 Cases, By Far

America has posted more than 7.5 million confirmed cases of COVID-19 so far, the highest figure in the world. The…

Chris Lange | Oct 7, 2020 at 11:32 AM EDT

Taiwan Liposome Gets the Go-Ahead for a Hydroxychloroquine COVID-19 Study

Taiwan Liposome shares shot up on Wednesday after the firm announced that it would be able to move forward with…

Chris Lange | Oct 7, 2020 at 10:26 AM EDT

Eli Lilly’s COVID-19 Antibody Treatment Closes In on the Goal

Eli Lilly shares made a handy gain on Wednesday after the company announced an update to its SARS-CoV-2 neutralizing antibody…

Chris Lange | Oct 6, 2020 at 11:05 AM EDT

Why Investors Have to Be Happy With Alexion’s Latest Update

Announcements that Alexion Pharmaceuticals made at its virtual Investor Day about expanding its pipeline and its guidance led to a…

Chris Lange | Oct 6, 2020 at 10:00 AM EDT

Vir Biotechnology Expands Its Late-Stage COVID-19 Study

Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in…

Jon C. Ogg | Oct 5, 2020 at 1:28 PM EDT

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that…

Chris Lange | Oct 5, 2020 at 12:04 PM EDT

ImmunoGen Sees Solid Win With FDA Update

ImmunoGen shares pushed higher to start out the week when the FDA provided an update for the firm’s treatment of…

Chris Lange | Oct 5, 2020 at 10:22 AM EDT

Corvus Shareholders Must Be Happy With This COVID-19 Study Update

Corvus Pharmaceuticals shares were sharply higher on Monday after the company announced updated data from its ongoing early-stage study in…

Chris Lange | Oct 5, 2020 at 10:07 AM EDT

MyoKardia Shareholders Are Getting a Really Sweet Payday

MyoKardia shares hit an all-time high early on Monday after it was announced that Bristol-Myers Squibb would be acquiring the…

Lee Jackson | Oct 5, 2020 at 9:50 AM EDT

Top Analyst Very Positive on Leading Medical Technology Health Care Stocks for 2021

These five high-conviction medical technology health care ideas from Jefferies all make sense for investors looking to gain exposure to…

Douglas A. McIntyre | Oct 5, 2020 at 8:26 AM EDT

COVID-19 Again Threatens New York City’s $850 Billion Economy

As COVID-19 begins to spread in New York City for a second time this year, hotspots have developed in over…

Chris Lange | Oct 2, 2020 at 11:58 AM EDT

Where We Stand on a Vaccine After Trump Catches COVID-19

President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of…

1 … 38 39 40 41 42 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

4 Very Profitable Biotech Stocks Expected to Soar Into 2021

Spinal Elements IPO Set to Turn Necks

Could Applied Therapeutics Stock Rise 300%?

This State Has the Fewest COVID-19 Cases, By Far

Taiwan Liposome Gets the Go-Ahead for a Hydroxychloroquine COVID-19 Study

Eli Lilly’s COVID-19 Antibody Treatment Closes In on the Goal

Why Investors Have to Be Happy With Alexion’s Latest Update

Vir Biotechnology Expands Its Late-Stage COVID-19 Study

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

ImmunoGen Sees Solid Win With FDA Update

Corvus Shareholders Must Be Happy With This COVID-19 Study Update

MyoKardia Shareholders Are Getting a Really Sweet Payday

Top Analyst Very Positive on Leading Medical Technology Health Care Stocks for 2021

COVID-19 Again Threatens New York City’s $850 Billion Economy

Where We Stand on a Vaccine After Trump Catches COVID-19

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Health and Healthcare Articles

All Health and Healthcare Articles

4 Very Profitable Biotech Stocks Expected to Soar Into 2021

Spinal Elements IPO Set to Turn Necks

Could Applied Therapeutics Stock Rise 300%?

This State Has the Fewest COVID-19 Cases, By Far

Taiwan Liposome Gets the Go-Ahead for a Hydroxychloroquine COVID-19 Study

Eli Lilly’s COVID-19 Antibody Treatment Closes In on the Goal

Why Investors Have to Be Happy With Alexion’s Latest Update

Vir Biotechnology Expands Its Late-Stage COVID-19 Study

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

ImmunoGen Sees Solid Win With FDA Update

Corvus Shareholders Must Be Happy With This COVID-19 Study Update

MyoKardia Shareholders Are Getting a Really Sweet Payday

Top Analyst Very Positive on Leading Medical Technology Health Care Stocks for 2021

COVID-19 Again Threatens New York City’s $850 Billion Economy

Where We Stand on a Vaccine After Trump Catches COVID-19

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts